Impact of Credentialing and Provider Privileges on Clinical Interventions made by Advanced Practice Pharmacists in California

Abstract Background The Advanced Practice Pharmacist licensure has provided an opportunity for pharmacists to expand their scope of practice in California; however, there have not been any studies in California assessing interventions made by advanced practice pharmacists as credentialed providers of care. Objective To assess clinical interventions made by advanced practice pharmacists as credentialed providers with clinical privileges in an independent community pharmacy. Methods This is a retrospective, observational study that assessed clinical interventions made by advanced practice pharmacists on patients referred for disease state management between January 2018 to December 2018. Pharmacist interventions were stratified into three levels of provider care: full privilege (FP), limited privilege (LP), and no privilege (NP). Results FP had the highest percentage of accepted recommendations (62.2 + 20.1%) whereas LP and NP had lower percentages of accepted recommendations, (41.9 + 12.0%) and (31.6 + 3.7%), respectively (p Conclusions Advanced practice pharmacists as credentialed providers with full privileging, or even limited privileging, made more successful clinical interventions, than without any privileges. Disclosures There was no outside funding source or sponsor for this project. None of the authors report any conflicts of interest. Preliminary data from this project was presented in abstract and poster form at the American Pharmacists Association (APhA) Annual Meeting 2019; March 22-25, 2019; in Seattle, Washington.